.jpg)
Announcement on behalf of major subsidiary,TOP PHARM.MEDICALWARE COMPANY LIMITED regarding BOD's resolution to the Ex-rights and dividend base date
2025.5.16
...
.jpg)
Announcement on behalf of major subsidiary,TOP PHARM. MEDICALWARE COMPANY LIMITED,regarding the important resolutions of 2025 Annual General Meeting
2025.5.16
...
.jpg)
TSH Board of Directors Approved the Consolidated Financial Statements For the Three Months Ended March 31, 2025
2025.5.8
...
TSH Biopharm Expands Rare Disease Portfolio, Unlocks New Opportunities in CNS Market
2025.5.6
...
Double Milestone for TSH Biopharm: Top 5% in Corporate Governance and Product Expansion into Macau
2025.5.1
...
.jpg)
